Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R21 Matrix-M malaria vaccine in healthy volunteers
NCT03970993Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jun 2019
- Primary completion
- Aug 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of R21/Matrix-M in malaria, sponsored by University of Oxford. Started Jun 2019; status: completed.
02
Drugs
R21/Matrix-M
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03970993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03970993.